These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19756524)

  • 1. Neural basis for a heritable phenotype: differences in the effects of apomorphine on startle gating and ventral pallidal GABA efflux in male Sprague-Dawley and Long-Evans rats.
    Qu Y; Saint Marie RL; Breier MR; Ko D; Stouffer D; Parsons LH; Swerdlow NR
    Psychopharmacology (Berl); 2009 Dec; 207(2):271-80. PubMed ID: 19756524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensory and sensorimotor gating-disruptive effects of apomorphine in Sprague Dawley and Long Evans rats.
    Breier MR; Lewis B; Shoemaker JM; Light GA; Swerdlow NR
    Behav Brain Res; 2010 Apr; 208(2):560-5. PubMed ID: 20080128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain differences in the gating-disruptive effects of apomorphine: relationship to gene expression in nucleus accumbens signaling pathways.
    Shilling PD; Saint Marie RL; Shoemaker JM; Swerdlow NR
    Biol Psychiatry; 2008 Apr; 63(8):748-58. PubMed ID: 18083141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the molecular basis for an inherited sensitivity to the startle-gating disruptive effects of apomorphine in rats.
    Swerdlow NR; Breier MR; Saint Marie RL
    Psychopharmacology (Berl); 2011 Aug; 216(3):401-10. PubMed ID: 21365203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat strain differences in startle gating-disruptive effects of apomorphine occur with both acoustic and visual prepulses.
    Weber M; Swerdlow NR
    Pharmacol Biochem Behav; 2008 Jan; 88(3):306-11. PubMed ID: 17900675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: time course studies.
    Qu Y; Swerdlow NR; Weber M; Stouffer D; Parsons LH
    Pharmacol Biochem Behav; 2008 Oct; 90(4):686-90. PubMed ID: 18579193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heritable differences in the dopaminergic regulation of sensorimotor gating. II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition.
    Swerdlow NR; Shoemaker JM; Auerbach PP; Pitcher L; Goins J; Platten A
    Psychopharmacology (Berl); 2004 Aug; 174(4):452-62. PubMed ID: 15300359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heritable differences in the dopaminergic regulation of behavior in rats: relationship to D2-like receptor G-protein function.
    Swerdlow NR; Krupin AS; Bongiovanni MJ; Shoemaker JM; Goins JC; Hammer RP
    Neuropsychopharmacology; 2006 Apr; 31(4):721-9. PubMed ID: 16123742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic differences in startle gating-disruptive effects of apomorphine: evidence for central mediation.
    Swerdlow NR; Shoemaker JM; Pitcher L; Platten A; Kuczenski R; Eleey CC; Auerbach P
    Behav Neurosci; 2002 Aug; 116(4):682-90. PubMed ID: 12148935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation.
    Weber M; Chang WL; Breier M; Ko D; Swerdlow NR
    Behav Pharmacol; 2008 Dec; 19(8):786-95. PubMed ID: 19020413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heritable differences in the dopaminergic regulation of sensorimotor gating. I. Apomorphine effects on startle gating in albino and hooded outbred rat strains and their F1 and N2 progeny.
    Swerdlow NR; Shoemaker JM; Platten A; Pitcher L; Goins J; Auerbach PP
    Psychopharmacology (Berl); 2004 Aug; 174(4):441-51. PubMed ID: 15300358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heritable differences in the effects of amphetamine but not DOI on startle gating in albino and hooded outbred rat strains.
    Swerdlow NR; Shoemaker JM; Platten A; Pitcher L; Goins J; Crain S
    Pharmacol Biochem Behav; 2003 Apr; 75(1):191-7. PubMed ID: 12759127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in rats.
    Swerdlow NR; Shilling PD; Breier M; Trim RS; Light GA; Marie RS
    Psychopharmacology (Berl); 2012 Dec; 224(3):349-62. PubMed ID: 22700037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists.
    Swerdlow NR; Martinez ZA; Hanlon FM; Platten A; Farid M; Auerbach P; Braff DL; Geyer MA
    J Neurosci; 2000 Jun; 20(11):4325-36. PubMed ID: 10818168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel rat strain with enhanced sensitivity to the effects of dopamine agonists on startle gating.
    Swerdlow NR; Breier M; Mora AB; Ko D; Shoemaker JM
    Pharmacol Biochem Behav; 2008 Jan; 88(3):280-90. PubMed ID: 17936348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity to the dopaminergic regulation of prepulse inhibition in rats: evidence for genetic, but not environmental determinants.
    Swerdlow NR; Platten A; Kim YK; Gaudet I; Shoemaker J; Pitcher L; Auerbach P
    Pharmacol Biochem Behav; 2001; 70(2-3):219-26. PubMed ID: 11701191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration.
    Swerdlow NR; Shoemaker JM; Bongiovanni MJ; Neary AC; Tochen LS; Saint Marie RL
    Pharmacol Biochem Behav; 2007 May; 87(1):1-10. PubMed ID: 17475315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of apomorphine and D-amphetamine on striatal c-Fos expression in Sprague-Dawley and Long Evans rats and their F1 progeny.
    Saint Marie RL; Neary AC; Shoemaker JM; Swerdlow NR
    Brain Res; 2006 Nov; 1119(1):203-14. PubMed ID: 16979142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity to drug effects on prepulse inhibition in inbred and outbred rat strains.
    Swerdlow NR; Shoemaker JM; Crain S; Goins J; Onozuka K; Auerbach PP
    Pharmacol Biochem Behav; 2004 Feb; 77(2):291-302. PubMed ID: 14751457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity.
    Kinney GG; Wilkinson LO; Saywell KL; Tricklebank MD
    J Neurosci; 1999 Jul; 19(13):5644-53. PubMed ID: 10377370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.